Literature DB >> 32476669

Locus of control in patients with Huntington disease: a cross-sectional study.

Brynne E Stainsby1, Silvano Mior1, Mark Guttman2.   

Abstract

BACKGROUND: Health locus of control (LOC) represents an individual's beliefs regarding one's ability to influence health outcomes. In patients with chronic and neurodegenerative diseases, greater internal LOC has been associated with lower levels of disability.
OBJECTIVE: To examine LOC in patients with Huntington disease (HD).
METHODS: A cross-sectional study of individuals affected by HD, stratified by disease status, was conducted. Participants completed a demographic questionnaire, the Internal Control Index (ICI), and the Hospital Anxiety and Depression Scales.
RESULTS: Thirty-four subjects completed the study. All groups demonstrated greater internal LOC (measured by ICI scores), and significant differences between groups were observed. Secondary analysis demonstrated relationships between depressive symptoms and anxiety symptoms, and ICI score and time from clinical diagnosis of HD.
CONCLUSION: As patients with chronic pain and neurodegenerative diseases such as HD are likely to present for chiropractic care, identifying factors such as anxiety, depression and LOC may affect patients' response to care. © JCCA 2020.

Entities:  

Keywords:  Huntington disease; anxiety; chronic pain; depression; internal-external control

Year:  2020        PMID: 32476669      PMCID: PMC7250512     

Source DB:  PubMed          Journal:  J Can Chiropr Assoc        ISSN: 0008-3194


  40 in total

1.  Clinical markers of early disease in persons near onset of Huntington's disease.

Authors:  J S Paulsen; H Zhao; J C Stout; R R Brinkman; M Guttman; C A Ross; P Como; C Manning; M R Hayden; I Shoulson
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

2.  Some implications of a social learning theory for the prediction of goal directed behavior from testing procedures.

Authors:  J B ROTTER
Journal:  Psychol Rev       Date:  1960-09       Impact factor: 8.934

Review 3.  Chronic pain and the measurement of personality: do states influence traits?

Authors:  David A Fishbain; Brandly Cole; R Brian Cutler; J Lewis; Hubert L Rosomoff; R Steele Rosomoff
Journal:  Pain Med       Date:  2006 Nov-Dec       Impact factor: 3.750

4.  Self-esteem, locus of control, hippocampal volume, and cortisol regulation in young and old adulthood.

Authors:  Jens C Pruessner; Mark W Baldwin; Katarina Dedovic; Robert Renwick; Najmeh Khalili Mahani; Catherine Lord; Michael Meaney; Sonia Lupien
Journal:  Neuroimage       Date:  2005-07-14       Impact factor: 6.556

Review 5.  A decade of research in locus of control: what have we learned?

Authors:  K Oberle
Journal:  J Adv Nurs       Date:  1991-07       Impact factor: 3.187

6.  Managing genetic discrimination: strategies used by individuals found to have the Huntington disease mutation.

Authors:  Y Bombard; E Penziner; J Decolongon; M L N Klimek; S Creighton; O Suchowersky; M Guttman; J S Paulsen; J L Bottorff; M R Hayden
Journal:  Clin Genet       Date:  2007-03       Impact factor: 4.438

7.  Paradox of a better test for Huntington's disease.

Authors:  A Maat-Kievit; M Vegter-van der Vlis; M Zoeteweij; M Losekoot; A van Haeringen; R Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

8.  Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.

Authors:  J C Hedreen; C E Peyser; S E Folstein; C A Ross
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

9.  The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.

Authors:  S Wiggins; P Whyte; M Huggins; S Adam; J Theilmann; M Bloch; S B Sheps; M T Schechter; M R Hayden
Journal:  N Engl J Med       Date:  1992-11-12       Impact factor: 91.245

10.  Active and passive coping strategies in chronic pain patients.

Authors:  Lynn A Snow-Turek; Margaret P Norris; Gabriel Tan
Journal:  Pain       Date:  1996-03       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.